Published • loading... • Updated
Moderna Stands By UK As Pharma Giants Criticize Pricing - Moderna (NASDAQ:MRNA)
The new centre can produce up to 100 million mRNA vaccine doses annually and supports research into cancer, rare diseases, and immune disorders, strengthening UK health security.
6 Articles
6 Articles


Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
Moderna Opens State-of-the-Art Manufacturing and R&D Facility at Harwell Campus - Harwell Campus
Back Moderna Opens State-of-the-Art Manufacturing and R&D Facility at Harwell Campus September 25, 2025 Share Tweet Life sciences and health, Science and innovation The Moderna Innovation and Technology Centre at Harwell Science and Innovation Campus, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population. The facility marks a cornerston…
Coverage Details
Total News Sources6
Leaning Left2Leaning Right0Center2Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium